Status:
COMPLETED
Prevalence of Obesity Hypoventilation Syndrome
Lead Sponsor:
AGIR à Dom
Conditions:
Obesity Hypoventilation Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale of the "BIO-OHS" study (Prevalence of Obesity Hypoventilation Syndrome): The overall prevalence of Obesity Hypoventilation Syndrome (OHS) has never been directly assessed in the general pop...
Detailed Description
No additional description
Eligibility Criteria
Inclusion
- 18 years old ans more
- BMI over 30 kg/M2
- Stable state (respiratory, metabolic and cardio-vascular) for the last 2 months
- Addressed to a clinical labs for a blood check-up whatever the prescription
Exclusion
- No social security
- Non cooperative patient, as judged by the investigator
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
1004 Patients enrolled
Trial Details
Trial ID
NCT01903135
Start Date
September 1 2013
End Date
March 1 2015
Last Update
February 1 2017
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Cabinet de Pneumologie Grenoble SUD
Échirolles, France
2
Laboratoire MEDIBIO Les Cedres
Échirolles, France
3
Hôpital Michallon, Laboratoire EFCR et Sommeil
Grenoble, France
4
Cabinet de Pneumologie Perpignan
Perpignan, France